[Hormone therapy of metastatic breast carcinoma].
D000616:Aminoglutethimide / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D047072:Aromatase Inhibitors; D001943:Breast Neoplasms / Q000188:drug therapy*; D002064:Buserelin / Q000627:therapeutic use*; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008593:Menopause; D009362:Neoplasm Metastasis
D000970:Antineoplastic Agents; D047072:Aromatase Inhibitors; D000616:Aminoglutethimide; D007987:Gonadotropin-Releasing Hormone; D002064:Buserelin
Neue Aspekte in der Hormontherapie des metastasierten Mammakarzinoms.